Introduction {#Sec1}
============

Adolescent obesity, a serious public health challenge, can persist into adulthood and contribute to premature development of type II diabetes (T2DM), dyslipidemia, increased cardiovascular disease, reduced quality of life, and early mortality \[[@CR1], [@CR2]\]. As nonsurgical treatments (e.g., lifestyle modification/s, medication/s) are modestly effective for extremely obese adolescents \[[@CR3]\], bariatric surgery has been increasingly utilized to achieve weight loss and resolution of comorbidities among such adolescents.

Laparoscopic sleeve gastrectomy (LSG) is increasingly employed in adolescents \[[@CR4]\], with good safety profile, durable weight loss, and comorbidity resolution \[[@CR5]\]. Although LSG is primarily a restrictive (rather than malabsorptive) procedure, it carries the risk of some nutritional deficiencies (NDs) related to postoperative restricted caloric intake, food intolerance, and/or insufficient supplementation \[[@CR6]\]. Moreover, preoperative nutritional deficiencies (due to high consumption of energy dense and nutritionally poor food), could worsen after LSG, if not recognized and treated \[[@CR7], [@CR8]\]. Nevertheless, LSG can improve obesity-related cardiometabolic risk factors \[[@CR9]\].

The literature on adolescent LSG reveals several gaps in terms of nutritional deficiencies and cardiometabolic outcomes. First, most bariatric adolescent studies have focused on gastric bypass/gastric band rather than on LSG \[[@CR10]\]. Additionally, most post-LSG adolescent research evaluated weight loss and perioperative complications \[[@CR11], [@CR12]\], overlooking the postoperative nutritional changes that are critical in adolescence. An exception is a post-LSG study of a narrow range of cardiometabolic and nutritional deficiency outcomes \[[@CR9]\] that did not assess any trace elements, despite their importance. Moreover, the evidence regarding post-LSG comorbidity resolution in adolescence is scarce, with many shortcomings, that include the reporting of: (1) only crude outcomes (e.g., dyslipidemia, with no details of individual lipids) \[[@CR13]\], or only single lipids (e.g., triglycerides or high-density lipoproteins) \[[@CR14], [@CR15]\]; or, (2) only cardiometabolic outcomes with no nutritional deficiency parameters \[[@CR14]\]. In addition, despite the rising adolescent obesity rates in the Eastern Mediterranean Region \[[@CR16]\], there exits only two published studies on LSG outcomes in adolescents: both examined cardiometabolic outcomes (no nutritional deficiency assessment) \[[@CR17], [@CR18]\], where the latter study had short follow-up (8 months).

Therefore, the current study bridged these gaps, comparing mean preoperative values of 4 anthropometric, 15 nutritional, and 10 cardiometabolic outcomes with postoperative changes at 2 years. We also assessed the postoperative evolution of de novo cases of nutritional and cardiometabolic outcomes. These factors highlight the importance of the current study and its contribution to the emerging evidence base.

Materials and Methods {#Sec2}
=====================

Study Design, Ethics, and Participants {#Sec3}
--------------------------------------

This retrospective study comprised all adolescents \[*N* = 102, aged 13--17 years, body mass index (BMI) ≥ 40 or ≥ 35 with comorbidities\] who underwent primary or revisional LSG between January 2011 and June 2015 at the Bariatric and Metabolic Surgery Centre, Hamad Medical Corporation, Doha, Qatar. The majority of the sample (97.5% of patients) had undergone primary LSG procedures, and only two patients had conversion from laparoscopic gastric band. The study was approved by Hamad Medical Corporation (Protocol No. 16308116). Follow-up information was missing for 23 adolescents; hence, the current analysis included the data of 79 adolescents.

Procedures and Data Collection {#Sec4}
------------------------------

We reviewed patients' medical charts/electronic records and retrieved data that included demographics and preoperative and 2-year postoperative information onAnthropometric outcomes \[weight, BMI, excess weight (EW) reduction, excess weight loss percentage (EWL%)\].Nutritional deficiency outcomes \[hemoglobin, hematocrit, mean corpusacular volume (MCV), iron, ferritin, total protein, albumin, calcium, magnesium, phosphate, zinc, copper, vitamin D, vitamin B12, folic acid\].Cardiometabolic outcomes \[changes in total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TGs), alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting blood glucose (FBG), hemoglobin A1c (HbA1c), parathyroid hormone (PTH), and uric acid levels\].

Standard referential values were adopted for all biochemical blood assays.

Assessment of Weight Change {#Sec5}
---------------------------

We assessed BMI \[weight (kg) / height (m^2^)\], EW \[current weight (kg) − ideal body weight (kg)\], EWL% \[(preoperative weight − current weight / (preoperative weight − ideal body weight) × 100\] \[[@CR19]\] and ideal body weight (kg) \[22 × height (m^2^)\] \[[@CR20]\].

Definition of Cardiometabolic Comorbidities {#Sec6}
-------------------------------------------

We defined dyslipidemia as TC ≥ 5.17 mmol/L, LDL ≥ 3.36 mmol/L, HDL ≤ 1 mmol/L, and TG ≥ 1.4 mmol/L; type 2 diabetes as FBG ≥ 7 mmol/L or HbA1c ≥ 6.5%); and prediabetes as HbA1c 5.7--6.4% or FBG 5.6--6.9 mmol/L \[[@CR21], [@CR22]\].

Definition of Cardiometabolic Comorbidity Resolution {#Sec7}
----------------------------------------------------

We focused only on complete resolution of comorbidities. We defined lipid resolution as TC \< 5.17 mmol/L, LDL \< 2.8 mmol/L, HDL \> 1.2 mmol/L, and TG \< 1 mmol/L; prediabetes resolution as FBG \< 5.5 mmol/L and HbA1c \< 5.7%); and T2DM resolution as FBG \< 5.5 mmol/L and HbA1c \< 6% without antidiabetic medication \[[@CR21], [@CR23]\].

Surgical Technique {#Sec8}
------------------

Procedure started with division of gastro-splenic ligament along the greater curvature 4 cm from the pylorus up to the left diaphragmatic crus with ultrasonic shears. Stomach was then mobilized and divided along the lesser curvature from antrum (4 cm from pylorus) up to the angle of His using buttressed (SeamGuard) linear 60-mm stapler (Covidien Tristapler) or Echelon Flex over the calibration tube (Midsleeve 38 Fr) introduced into the stomach. Specimen was removed through the umbilical port. Procedure was concluded with methylene blue leak test.

Nutritional Deficiency Management Protocol {#Sec9}
------------------------------------------

Adolescents with vitamin/s and/or mineral deficiencies in the preoperative assessment received treatment accordingly prior to surgery. In addition, any ND identified postoperatively was addressed as indicated. All patients were restricted to a liquid diet during the first three postoperative weeks with protein shake supplement provided for each patient to ensure adequate protein intake. Standardized nutritional supplements were also provided. These included daily multivitamin tablets containing vitamins A (retinol) C, D3, E K, B1 (thiamine), B2, B3, B5, B6 (pyridoxine), B8, B12 (cobalamin), and folate and the minerals chrome, iron, magnesium, selenium, and zinc.

Statistical Analysis {#Sec10}
--------------------

Categorical and continuous values were expressed as frequencies (percentages) and means ± SDs. Descriptive statistics were used to summarize demographic, clinical, anthropometric, nutritional, cardiometabolic, and liver function parameters and other related characteristics. Kolmogorov-Smirnov test was used to test for normality of the data. Paired *t* test was used to compare preoperative and postoperative (2 years post-LSG) mean changes in anthropometric, nutritional, cardiometabolic, and liver function parameters (quantitative outcome measures). Statistical analyses were performed using statistical package SPSS 22.0 (SPSS Inc., Chicago, IL); two-tailed *P* values \< 0.05 were considered statistically significant.

Results {#Sec11}
=======

Changes of Anthropometric Parameters {#Sec12}
------------------------------------

The sample comprised 36 males (45%), mean age 15.99 ± 1.07 years (range, 13--17 years). At 2-year follow-up (*M* = 24.2 ± 12.2 months), significant reductions were found in weight, BMI, and excess weight (Table [1](#Tab1){ref-type="table"}).Table 1Mean preoperative and postoperative anthropometric values of the study sampleParameterPreop\
*M* (SD)Postop^a^\
*M* (SD)*P*Difference\
*M* (SD)Weight126.15 (22.76)78.5 (13.17)\< 0.000151.82 (28.05)BMI (kg/m^2^)46.04 (5.99)28.30 (6.07)\< 0.000117 (6.24)EW (kg)66 (19.54)21 (14.9)\< 0.000147.94 (19.84)EWL (%)--81.08 (19.65)----*M* mean, *SD* standard deviation, *Difference* preop value minus postop value, *BMI* body mass index, *EW* excess weight, *EWL (%*) excess weight loss (%), --- not applicable^a^Measured at a mean of 24.2 months

Changes of Nutritional Parameters {#Sec13}
---------------------------------

Table [2](#Tab2){ref-type="table"} shows that the only preoperative deficiency pertained to vitamin D (*M* = 11.73 ± 6.06 ng/mL), and this deficiency persisted postoperatively (*M* = 17.73 ± 9.33 ng/mL). The preoperative and postoperative mean values of all remaining nutritional parameters were normal. Compared to preoperative levels, significant increases in the mean levels of hematocrit (only for males), MCV, iron, and vitamin D were detected postoperatively; conversely, significant decreases were found in mean levels of total protein, copper, and vitamin B12.Table 2Preoperative and postoperative mean values of nutritional parametersParameterNormal values (unit)PreopPostop^a^Difference\
*M* ± SD*PM* ± SD*M* ± SDHemoglobin Male13.8--16 (mg/dL)14.10 ± 1.2514.43 ± 2.010.28 ± 1.90.40 Female12.1--16 (mg/dL)12.52 ± 1.1512.29 ± 1.340.22 ± 1.10.17Hematocrit Male34.8--43.9 (%)43.3 ± 2.9344.79 ± 2.421.3 ± 2.80.01 Female34--40.7 (%)38.73 ± 2.8938.01 ± 3.68− 0.74 ± 3.740.21MCV83--101 (f/L)81.16 ± 6.0383.45 ± 6.682.29 ± 4.12\< 0.0001Iron5.4--28.6 (μmol/L)10.31 ± 4.8715.11 ± 7.874.80 ± 4.89\< 0.0001Ferritin11--304 (mcg/L)29.50 ± 25.1934.72 ± 37.795.22 ± 25.620.64Total protein64--83 (g/L)73 ± 4.1669.88 ± 4.63− 3.13 ± 5.36\< 0.0001Albumin40--150 (mg/L)41.14 ± 4.0640.38 ± 4.67− 0.77 ± 4.160.13Calcium2.1--2.5 (mmol/L)2.28 ± 0.122.55 ± 1.790.28 ± 1.810.32Magnesium0.72--1.04 (mmol/L)0.81 ± 0.040.81 ± 0.040.00 ± 0.060.91Phosphate0.89--1.66 (mmol/L)1.55 ± 0.221.50 ± 0.19− 0.05 ± 0.150.40Zinc10.1--16.8 (μmol/L)12.75 ± 1.2511.98 ± 1.22− 0.77 ± 1.840.28Copper11--22 (μmol/L)21.32 ± 2.2616.87 ± 3.45− 4.45 ± 3.910.04Vitamin D30--50 (ng/mL)11.73 ± 6.0617.73 ± 9.336.00 ± 11.11\< 0.0001Vitamin B12133--675 (pmol/L)256.51 ± 106.71271.22 ± 227.64− 14.71 ± 229.170.036Folic acid4--45 (nmol/L)20.41 ± 11.3014.40 ± 10.74− 6.01 ± 12.420.07*M* mean, *SD* standard deviation, *Difference* postoperative value minus preoperative value, *MCV* mean cell volume^a^Mean follow-up = 24.2 ± 12.28 months

Table [3](#Tab3){ref-type="table"} shows the subset of the sample with preoperative or postoperative nutritional deficiencies or both. Preoperatively, vitamin D deficiency was observed across most (96.4%) adolescents, followed by ferritin, albumin, iron, and other deficiencies (range, 4.7--39.4%). Postoperatively, vitamin D deficiency was still observed in 89.3% of adolescents, followed by albumin, ferritin, hemoglobin, iron, and other deficiencies (range, 4.6--38%). However, the differences between preoperative and postoperative deficiencies were not statistically significant.Table 3Evolution of nutritional deficiencies among the study sampleParameterPreop\
*N* (%)Postop^a^\
*N* (%)*P* ^b^De novo\
*N* (%)Hemoglobin Male13 (39.4)5 (15.2)0.021 (3.0) Female13 (31.7)12 (29.3)0.994 (9.8)Hematocrit Male0 (0)2 (5.9)NA5 (5.9) Female2 (4.9)4 (9.8)0.694 (9.8)MCV (micro def.)^d^ Male7 (20.6)2 (5.9)0.060 (0) Female11 (27.5)8 (20)0.452 (5)Iron5 (20.8)4 (16.7)0.991 (4.2)Ferritin2 (33.3)2 (33.3)0.991 (16.7)Total protein0 (0)3 (4.6)NA3 (4.6)Albumin21 (29.6)27 (38)0.2914 (19.7)Calcium2 (4.7)2 (4.7)0.991 (2.3)Magnesium0 (0)0 (0)NA0 (0)Phosphate0 (0)0 (0)NA0 (0)Zinc0 (0)0 (0)NA0 (0)Copper0 (0)1 (16.7)NA1 (16.7)Vitamin D54 (96.4)50 (89.3)0.292 (3.6)Vitamin B123 (6.7)6 (15.3)0.384 (8.9)Folic acid0 (0)0 (0)NA0 (0)*N* number, *NA* not applicable, *MCV* mean cell volume^a^Mean follow-up = 24.2 ± 12.28 months^b^McNemar chi-squared test^c^Percentage of participants with deficiency calculated as the number of participants (among those for whom sufficient data were available both preoperatively and postoperatively to determine whether the coexisting condition was present), divided by the number of participants (among those for whom sufficient data were available preoperatively and postoperatively)^d^Representing microcytic deficiency (MCV \< 83) in anemic patients only (i.e., patient with deficient hemoglobin levels)

Evolution of Nutritional Deficiencies (De Novo Cases) {#Sec14}
-----------------------------------------------------

Table [3](#Tab3){ref-type="table"} depicts postoperative de novo cases with nutritional deficiencies. The most frequent de novo deficiency was low albumin (14 patients), followed by hematocrit, hemoglobin, vitamin B12, vitamin D, and other de novo deficiencies (range, 1--5 patient/s). De novo deficiencies of minerals and trace element were either absent (e.g., magnesium, phosphate, zinc) or rare (e.g., copper, one patient).

Changes of Cardiometabolic Parameters {#Sec15}
-------------------------------------

Table [4](#Tab4){ref-type="table"} shows elevated levels of preoperative ALT, FBG, HbA1c, and uric acid. Postoperatively, mean values of all initially elevated cardiometabolic parameters returned to normal, except for uric acid, which remained slightly above the upper normal limit (356 ± 85.52 μmol/L). Additionally, significant decreases (i.e., return to normal) were observed for TC, LDL, HDL, TG, FBG, HbA1c, and liver enzymes' mean values. Conversely, no significant decreases were detected in the mean values of PTH and uric acid.Table 4Preoperative and postoperative mean values of cardiometabolic parametersParameterNormal value (unit)Preop\
*M* ± SDPostop^a^\
*M* ± SDDifference\
*M* ± SD*P*TC\< 5.17 (mmol/L)4.57 ± 0.744.28 ± 0.610.29 ± 0.780.02LDL\< 3.36 (mmol/L)2.92 ± 0.782.67 ± 0.660.26 ± 0.730.04HDL\> 1 (mmol/L)1.14 ± 0.261.29 ± 0.33− 0.14 ± 0.270.003TG\< 1.7 (mmol/L)1.13 ± 0.470.83 ± 0.410.30 ± 0.500.001ALT9--24 (U/L)31.03 ± 19.5417.68 ± 15.6713.35 ± 19.40\< 0.0001AST13--26 (U/L)23.12 ± 9.7918.14 ± 8.854.98 ± 11.850.002FBG3.5--5.5 (mmol/L)5.71 ± 3.144.85 ± 2.050.86 ± 2.180.006HbA1c4.8--6 (%)6.55 ± 2.615.48 ± 1.441.07 ± 1.590.001PTH15--65 (pg/mL)56.58 ± 23.2352.83 ± 40.543.75 ± 42.300.77Uric Acid150--350 (mmol/L)355 ± 67.97356 ± 85.52− 1.11 ± 38.580.93*M* mean, *SD* standard deviation, *Difference* postoperative value minus preoperative value, *TC* total cholesterol, *LDL* low-density lipoprotein, *HDL* high-density lipoprotein, *TG* total triglycerides, *ALT* alanine amino transferase, *AST* aspartate aminotransferase, *FBG* fasting blood glucose, *HbA1c* glycosylated hemoglobin^a^Mean follow-up = 24.2 ± 12.28 months

Evolution of Cardiometabolic Risk Factors (De Novo Cases) {#Sec16}
---------------------------------------------------------

Significant postoperative improvements were found in the percentage of patients with elevated LDL, ALT, and AST. Similar improvements were seen in patients with T2DM and prediabetes (Table [5](#Tab5){ref-type="table"}). We also observed a 100% remission among adolescents with preoperative elevated TG levels and prediabetes. The postoperative remissions of the remaining cardiometabolic parameters ranged between 21.1 and 90%. The numbers of de novo cases were generally low across most cardiometabolic parameters, with the exception of HDL (four de novo low HDL cases), LDL (three de novo elevated LDL cases), and AST (three de novo elevated AST cases).Table 5Evolution of cardiometabolic parameters of the sampleParameterPreopPostop^a^*P* ^b^RemissionDe novo*N* (%)*N* (%)*N* (%)*N* (%)TC10 (20.8)3 (6.3)0.0613 (29.5)4 (9.1)LDL11 (66.1)7 (38.9)\< 0.00018 (21.1)2 (5.37)HDL12 (32.4)7 (18.90.2737 (100)0 (0)TG4 (10.3)1 (2.6)0.3835 (83.3)0 (0)ALT29 (45.3)7 (10.9)\< 0.000122 (75.9)0 (0)AST14 (24.1)5 (8.6)0.0312 (85.7)3 (5.2)Prediabetes17 (12.6)4 (5.0)\< 0.000117 (100.0)0 (0)T2DM10 (12.6)6 (7.6)\< 0.00018 (80.0)0 (0)Uric acid6 (66.7)3 (33.3)0.253 (50.0)0 (0)PTH4 (33.3)2 (16.7)0.633 (75.0)1 (8.3)*TC* total cholesterol, *NA* not applicable, *LDL* low-density lipoprotein, *HDL* high-density lipoprotein, *ALT* alanine aminotransferase, *AST* aspartate aminotransferase, *T2DM* type 2 diabetes^a^Mean follow-up = 24.2 ± 12.28 months^b^McNemar chi-squared test^c^Percentage of participants with metabolic abnormality calculated as the number of participants (among those for whom sufficient data were available both preoperatively and postoperatively to determine whether the coexisting condition was present), divided by the number of participants (among those for whom sufficient data were available preoperatively and postoperatively)

Discussion {#Sec17}
==========

Few studies have examined the nutritional and cardiometabolic outcomes of adolescent bariatric surgery beyond 1 year \[[@CR9], [@CR24]\]. To the best of our knowledge, this is the first research in the Eastern Mediterranean Region assessing a comprehensive range of LSG outcomes. Two years after LSG, adolescents generally showed impressive improvements in anthropometric (weight, BMI, EWL%, Table [1](#Tab1){ref-type="table"}), nutritional (hematocrit, MCV, iron, vitamin D, Table [2](#Tab2){ref-type="table"}), and cardiometabolic (TC, LDL, HDL, TG, T, ALT, AST, Table [2](#Tab2){ref-type="table"}) outcomes.

Anthropometric Outcomes {#Sec18}
-----------------------

We observed significant weight reduction (mean = 51.82 kg) that exceeded post-LSG weight reductions reported by recent studies (39 kg in USA and 40 kg in France) \[[@CR9], [@CR14]\]. Interestingly, this higher weight reduction occurred despite the fact that mean BMI in our study was lower than that reported in previously mentioned studies \[[@CR9]\], although the literature suggests that, among adults, more weight reduction is usually achieved in patients with higher preoperative BMI \[[@CR25]\]. Such controversy suggests that the relationship between the initial BMI and the magnitude of postoperative weight reduction might not be entirely linear, with other intervening factors potentially influencing/moderating this relationship. Future research should explore these relationships. Likewise, mean decline in BMI and EWL% in our study agreed with or exceeded the values reported elsewhere \[[@CR9], [@CR26]\]. The finding that most adolescents in our study achieved and maintained a meaningful weight loss for at least 2 years postoperatively suggests that compared to adults, adolescents treated with bariatric surgery may have a better potential for the reversal of anthropometric parameters \[[@CR9]\].

Nutritional Outcomes {#Sec19}
--------------------

Generally, we observed no preoperative or postoperative deficiencies of trace elements/minerals, except for one de novo case of copper deficiency. Adequate levels of trace elements/minerals are important, given their critical roles in the immune system, cell/neuromuscular functions, wound healing, and bone health. We found no comparable published studies on post-bariatric surgery trace element/mineral changes among adolescents. Nevertheless, among adult populations, others have reported post-bariatric surgery deficiencies in zinc of 7--15% and 0--5% in copper \[[@CR27]\].

Vitamin D was the most prevalent deficiency in our study (96.4% preoperatively), and exceeded deficiencies reported by others \[[@CR28], [@CR29]\]. Moreover, this deficiency persisted 2 years later (89.3% postoperatively) and remained higher than other reports \[[@CR9]\]. Such vitamin D deficiency may be driven by underexposure to ultraviolet radiation, malabsorption, and decreased bioavailability due to enhanced uptake by adipose tissue \[[@CR30]\]. Despite of persistent vitamin D deficiency preoperatively and postoperatively, the incidence of hypocalcemia remained low (4.7%). On the other hand, hyperparathyroidism related to vitamin D deficiency was present among only 33.3 and 16.7% of adolescents preoperatively and postoperatively, lower than levels in other studies \[[@CR6], [@CR31]\], probably due to the high prevalence of vitamin D among our sample. The persistence of postoperative vitamin D deficiency and secondary hyperparathyroidism highlights the need to assess the optimal vitamin D and calcium supplementation doses necessary to preserve bone health.

With regards to hemoglobin, about one third of our adolescents had low preoperative hemoglobin levels, confirming the high risk of anemia among young populations \[[@CR32]\]. Postoperatively, the percentage of patients with low hemoglobin levels significantly decreased among males (from 39.4 to 15.2%), but only modestly reduced among females (from 31.7 to 29.3%), probably due to menstrual loss, suggesting the need for additional iron supplementation among young females. However, our percentage of patients with iron deficiency was twice than that reported among adolescents who underwent gastric banding \[[@CR33]\], probably due to the decreased hydrochloric acid production essential for iron absorption after gastric resection, along with the reduced intake of iron-rich food such as red meat \[[@CR34]\].

In terms of albumin levels, the 29.6% rate of albumin deficiency was high compared with other studies (3%) \[[@CR9]\]. The percentage of our patients with hypoalbuminemia increased to 38.3% postoperatively (14 de novo cases), in contrast to other research that reported no albumin deficiency post-LSG \[[@CR9]\]. This albumin deficiency can be explained by LSG's restrictive nature, and the observed intolerance to protein-rich food postoperatively \[[@CR35]\]. High post-LSG protein intake is hence encouraged for adolescents especially with the rapid weight loss during the first year. Protein shake supplements can be provided as and alternative in case of protein intolerance.

Cardiometabolic Outcomes {#Sec20}
------------------------

Generally, the percentage of patients with cardiometabolic abnormalities significantly decreased postoperatively. Post-LSG lipid profile among adolescents is critical, as there is correlation between adolescent combined dyslipidemia (elevated LDL and TG, low HDL) and atherosclerosis, with subsequent premature coronary artery disease \[[@CR36]\]. Hence, understanding the lipid dynamics among post-LSG adolescents is critical. In our study, the majority of adolescents exhibited elevated LDL levels preoperatively, higher than others \[[@CR37]\]. However, our LDL levels significantly decreased postoperatively, matching findings observed in Saudi Arabia \[[@CR17]\]. Likewise, we detected 83.3% hypertriglyceridemia remission rate, confirming previous findings \[[@CR14], [@CR17]\]. Such improvements in hypertriglyceridemia after bariatric surgery can be due to reduced abdominal fat and decreased flux of free fatty acids to the liver, resulting in decreased hepatic secretion of triglyceride-rich lipoproteins \[[@CR38]\].

In addition, the percentage of our patients with low HDL exceeded that reported for obese adolescents in the USA \[[@CR37]\]. Despite such elevated preoperative levels, we observed a significant drop in the low HDL levels postoperatively with (100%) remission rate, higher than reported in by others \[[@CR15], [@CR17]\]. Such increase of HDL is attributed to increased physical activity and was found protective against atherosclerosis mainly through suppressing LDL accumulation, inflammation, and thrombosis \[[@CR39]\]. Finally, the incidence of our elevated TC preoperatively is within the range reported by others \[[@CR17], [@CR40]\], and while it significantly decreased postoperatively, our remission rate (29.5%) was lower than in other studies (58.3%) \[[@CR41]\]. Overall, our observed improvements in lipid profile support the proposal that adolescents may have better potential than adults for the reversal of dyslipidemia \[[@CR9]\]. However, randomized controlled trials are needed to demonstrate LSG's long-term effects on reduction of atherogenic lipids and subsequent cardiovascular disease prevention in adulthood.

In terms of uric acid, in Japan, 20.7% of obese adolescents had hyperuricemia \[[@CR42]\], probably linked to metabolic syndrome and insulin resistance \[[@CR43], [@CR44]\]. Our incidence of preoperative hyperuricemia decreased from 66.7 to 33.3% postoperatively, possibly due to enhanced insulin sensitivity after LSG \[[@CR45]\].

Among obese adolescents, an increased incidence of nonalcoholic fatty liver disease (NAFLD) was reported. Elevated aminotransferases act as surrogate NAFLD markers which predict subsequent diabetes, metabolic syndrome, and cirrhosis \[[@CR46], [@CR47]\]. Others have reported elevated ALT among obese boys and girls \[[@CR48]\]. Our prevalence of elevated ALT levels significantly decreased postoperatively with 75.9% remission rate. Likewise, obese adolescents also have higher prevalence of elevated AST compared to normal weight adolescents (14.9 vs. 6.6%) \[[@CR49]\]. Our preoperative AST prevalence, although higher than others \[[@CR50]\], significantly decreased postoperatively. We agree with others where liver enzymes improved 1 year after surgery amounting to 55.6% (post-gastric bypass) and 33.3% (post-gastric band) \[[@CR51]\], and with a study in Sweden that reported marked AST and ALT improvements post-gastric bypass \[[@CR24]\]. Factors that improve liver enzymes include the beneficial effects of weight loss, better insulin sensitivity, improved dyslipidemia, and reduced inflammatory markers \[[@CR52]\]. Hence, early bariatric surgery should be considered for adolescents with NAFLD. Future research should further examine such effects.

Although the 12.6% prevalence of prediabetes in our study was higher than that reported by others \[[@CR2], [@CR53]\], we observed 100% remission prediabetes rate which is identical to findings in other studies \[[@CR9], [@CR17]\]. However, our preoperative T2DM prevalence was lower than that in Saudi Arabia (23%) \[[@CR17]\] and USA (14%) \[[@CR2]\]. Although T2DM traditionally affects adults, its incidence has dramatically increased among adolescents \[[@CR54]\], probably linked to sedentary lifestyle, obesity, and insulin resistance \[[@CR55]\]. Our prevalence of T2DM significantly decreased post-LSG (80% remission rate), comparable to other remissions reported after LSG (88.5--100%) \[[@CR9], [@CR17]\], gastric banding (59.1%), and gastric bypass (78.6%) \[[@CR52]\].

Prediabetes and T2DM remission and concomitant HbA1c improvements are related to better insulin sensitivity and glucose metabolism that influence weight-dependent (body weight loss) and independent (hormonal glucagon-like peptide 1) pathways. This hormone stimulates glucose-dependent insulin secretion from β cells, inhibits glucagon secretion, and may increase peripheral glucose uptake and insulin sensitivity \[[@CR56]\]. Given the potential complications of adolescent T2DM, improvements of T2DM post-bariatric surgery provide further evidence for its validity as an effective treatment option of adolescent T2DM \[[@CR57]\].

This study has limitations. It would have been beneficial to have patient data on preoperative and postoperative food consumption, diet regimens, and intake of vitamins/other supplements that could have influenced the observed nutritional and cardiometabolic changes. In addition, we provide our post-LSG patients with specific dietary/supplementation protocols, but compliance is difficult to assess. Longer (5 years) post-LSG follow-up of our adolescents' nutritional profiles would have been useful to assess other longer term effects. Finally, we had a 77.5% follow-up rate, slightly lower than the ideal follow-up of ≥ 80%, which is rarely accomplished even in the most cited bariatric surgery outcome research \[[@CR58]--[@CR60]\]. Nevertheless, the study has several strengths. We examined a wide variety of parameters (25 anthropometric, nutritional, and cardiometabolic). To date, no study has examined, in similar detail, such as broad range of parameters after LSG among adolescents. We focused on only one bariatric procedure (LSG) rather than a range of bariatric techniques (gastric band, gastric bypass); hence, our findings are specific to post-LSG consequences, "unaffected" by results of other bariatric procedures that could have potentially influenced the nutritional/cardiometabolic outcomes after surgery. With a few exceptions, very few studies have achieved such results \[[@CR9], [@CR17]\].

Conclusion {#Sec21}
==========

Our findings confirm that, among obese adolescents, LSG achieves significant weight loss and improves anthropometric parameters and 10 cardiometabolic risk factors, without the development of trace element deficiency after surgery. Conversely, the preoperative nutritional deficiencies (vitamin D, anemia, and hypoalbuminemia) persisted or worsened postoperatively. Such nutritional deficiencies warrant careful and specific preoperative surveillance and appropriate postoperative monitoring and nutritional supplementation, especially during the adolescence period, in order to ensure healthy development and growth. Longer follow-up of adolescents' nutritional profiles is recommended to assess other potential effects of LSG.
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